Fred Hutchinson Cancer Research Center

Biotech

Affini-T banks $175M to enter crowded KRAS-cancer field

Affini-T Therapeutics is hoping that $175 million in new fundraising is enough to launch two oncology programs into human trials by 2023.
Max Bayer Mar 22, 2022 7:30am

Treating leukemia by targeting tumor 'seeds,' 'essential genes'

Mar 15, 2022 8:59am

TCR-T cells fend off evasive leukemia, solid tumors in mice

Feb 9, 2022 2:00pm

Blockbuster cancer med Keytruda may help flush out dormant HIV

Jan 26, 2022 2:00pm

Improving CAR-T with more sensitive tumor ID

Aug 25, 2021 8:15am

Sanofi pays $160M for mRNA tech to reprogram T cells in vivo

Apr 12, 2021 7:45am